Gradient Investments LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17
-99.8%
2
-99.4%
0.00%
Q2 2023$7,750
+10.1%
312
-33.3%
0.00%
Q1 2023$7,039
+27.1%
4680.0%0.00%
Q4 2022$5,536
+84.5%
4680.0%0.00%
Q3 2022$3,000
+50.0%
4680.0%0.00%
Q2 2022$2,000
-33.3%
468
+51.0%
0.00%
Q1 2022$3,000
-40.0%
310
+19.2%
0.00%
Q4 2021$5,000
-44.4%
2600.0%0.00%
Q3 2021$9,0002600.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders